Delivery Order SPE2DB20D1110-SPE2DB24FJ84D
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,564,604,935 units of Methylphenidate ER 27 mg tablets in 100-count packages, with a ceiling value of $3,128.56. The contract has a firm fixed price pricing type and is a delivery order without any set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,510,706 units of Methylphenidate ER 18 mg tablets in 100-count packages. The Firm Fixed Price contract, valued at $1,613.35, has a completion date of November 22, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,173.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,236,639 units of Methylphenidate ER 18 mg tablets, with a performance period through May 14, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,370,660 units of methylphenidate ER 18 mg tablets. The firm-fixed-price delivery order, valued at $5,038.82, has an ultimate completion date of November 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999...
- This federal contract award, with ID SPE2DB22D2009|SPE2DB24FL6HR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,676,885 units of Methylphenidate ER 54 mg tablets in 100 count bottles. The contract has a firm fixed price of $3,626.65 and an ultimate completion date of November 2, 2023. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, with ID SPE2DB22D2005|SPE2DB25FJLD1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,955,658 units of Methylphenidate ER 18 mg tablets. It is a firm fixed-price delivery order contract with a ceiling value of $1,353.06 and a period of performance ending on April 16, 2025. Amerisourcebergen Drug Corp is the prime contractor...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Methylphenidate ER 18 mg tablets in 100-count bottles. The contract, valued at $1,411.77, is a Firm Fixed Price Delivery Order that will be completed by June 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025,...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB24FM6Y6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,731,548 units of Methylphenidate ER 18 mg tablets. The contract has a firm fixed price, a ceiling value of $5,425.95, and an ultimate completion date of February 16, 2024. The contract was awarded on February 15, 2024, and there was no set-aside designation used. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $4,374.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,926,858 units of Methylphenidate ER 27 mg tablets in 100-count bottles. The contract has a period of performance through April 16, 2025 and is a firm-fixed-price delivery order. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The award, valued at $1,028.17, is for the delivery of 4,564,339,501 Methylphenidate ER 27 mg tablets in 100-count bottles. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 22, 2024. Amerisourcebergen also holds a larger...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB24FJ84DDelivery Order
This federal contract award, identified as SPE2DB20D1110|SPE2DB24FJ84D, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,221,284 units of Methylphenidate ER 18 mg tablets in 100-count bottles. The award has a ceiling value of $3,233.02 and a completion date of January 4, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 1/3/24 |